Fulcrum Therapeutics Inc (FULC)
3.22
+0.25
(+8.42%)
USD |
NASDAQ |
Nov 22, 12:01
Fulcrum Therapeutics Total Assets (Quarterly): 279.01M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 279.01M |
| June 30, 2024 | 294.26M |
| March 31, 2024 | 232.59M |
| December 31, 2023 | 257.69M |
| September 30, 2023 | 278.88M |
| June 30, 2023 | 300.33M |
| March 31, 2023 | 321.12M |
| December 31, 2022 | 226.68M |
| September 30, 2022 | 247.80M |
| June 30, 2022 | 195.23M |
| March 31, 2022 | 220.25M |
| December 31, 2021 | 235.00M |
| Date | Value |
|---|---|
| September 30, 2021 | 255.55M |
| June 30, 2021 | 137.88M |
| March 31, 2021 | 156.48M |
| December 31, 2020 | 129.58M |
| September 30, 2020 | 142.22M |
| June 30, 2020 | 144.86M |
| March 31, 2020 | 94.86M |
| December 31, 2019 | 110.44M |
| September 30, 2019 | 115.96M |
| June 30, 2019 | 65.15M |
| March 31, 2019 | 75.59M |
| December 31, 2018 | 85.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
94.86M
Minimum
Mar 2020
321.12M
Maximum
Mar 2023
213.03M
Average
229.64M
Median
Total Assets (Quarterly) Benchmarks
| Bioventus Inc | 769.49M |
| Arcturus Therapeutics Holdings Inc | 370.65M |
| Johnson & Johnson | 178.29B |
| Pfizer Inc | 219.48B |
| Tenon Medical Inc | 13.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.72M |
| Shareholders Equity (Quarterly) | 257.29M |